Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Hartmann

Showing results (101-110 of 251) with videos related to

Pageof 26
Sort By:
Archives Francaises De Pediatrie|October 1, 1991
[Dumbbell neuroblastoma. Experience at the Gustave Roussy Institute in 38 cases treated from 1982 to 1987]D Plantaz, O Hartmann, C Kalifa, et al.
Pediatric Hematology and Oncology|January 1, 1987
Incubation of autologous bone marrow graft with ASTA Z 7557: comparative studies of hematological reconstitution after purged or nonpurged bone marrow transplantationF Beaujean, O Hartmann, J Pico, et al.
Archives Francaises De Pediatrie|May 1, 1981
[Non-Hodgkin malignant lymphoma in children. Practical aspects]C Patte, R Gérard-Marchant, B Caillou, et al.
Bone Marrow Transplantation|June 1, 1993
Systemic Candida infection in pediatric BM autotransplantation: clinical signs, outcome and prognosisM Besnard, O Hartmann, D Valteau-Couanet, et al.
Bulletin Du Cancer|January 1, 1990
[Role of high-dose chemotherapy followed by bone marrow autograft in the treatment of metastatic Ewing's sarcoma in children]O Hartmann, O Oberlin, F Beaujean, et al.
Chirurgie Pediatrique|January 1, 1990
[Localized thoracic neuroblastoma: the role of surgery and therapeutic results. Apropos of 40 cases]H Rubie, O Hartmann, A Giron, et al.
Bulletin Du Cancer|January 1, 1988
[Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases]J Lumbroso, F Guermazi, O Hartmann, et al.
Bone Marrow Transplantation|August 1, 1992
Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 childrenV Méresse, O Hartmann, G Vassal, et al.
Cancer|April 1, 1995
Morphologic and molecular cytogenetics in neuroblastomaH Avet-Loiseau, A M Venuat, J Benard, et al.
Bone Marrow Transplantation|November 5, 2003
In children and adolescents, the pharmacodynamics of high-dose busulfan is dependent on the second alkylating agent used in the combined regimen (melphalan or thiotepa)J Bouligand, I Boland, D Valteau-Couanet, et al.
Pageof 26

Showing results (101-110 of 251) with videos related to

Sort By:
Pageof 26
Archives Francaises De Pediatrie|October 1, 1991
[Dumbbell neuroblastoma. Experience at the Gustave Roussy Institute in 38 cases treated from 1982 to 1987]D Plantaz, O Hartmann, C Kalifa, et al.
Pediatric Hematology and Oncology|January 1, 1987
Incubation of autologous bone marrow graft with ASTA Z 7557: comparative studies of hematological reconstitution after purged or nonpurged bone marrow transplantationF Beaujean, O Hartmann, J Pico, et al.
Archives Francaises De Pediatrie|May 1, 1981
[Non-Hodgkin malignant lymphoma in children. Practical aspects]C Patte, R Gérard-Marchant, B Caillou, et al.
Bone Marrow Transplantation|June 1, 1993
Systemic Candida infection in pediatric BM autotransplantation: clinical signs, outcome and prognosisM Besnard, O Hartmann, D Valteau-Couanet, et al.
Bulletin Du Cancer|January 1, 1990
[Role of high-dose chemotherapy followed by bone marrow autograft in the treatment of metastatic Ewing's sarcoma in children]O Hartmann, O Oberlin, F Beaujean, et al.
Chirurgie Pediatrique|January 1, 1990
[Localized thoracic neuroblastoma: the role of surgery and therapeutic results. Apropos of 40 cases]H Rubie, O Hartmann, A Giron, et al.
Bulletin Du Cancer|January 1, 1988
[Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases]J Lumbroso, F Guermazi, O Hartmann, et al.
Bone Marrow Transplantation|August 1, 1992
Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 childrenV Méresse, O Hartmann, G Vassal, et al.
Cancer|April 1, 1995
Morphologic and molecular cytogenetics in neuroblastomaH Avet-Loiseau, A M Venuat, J Benard, et al.
Bone Marrow Transplantation|November 5, 2003
In children and adolescents, the pharmacodynamics of high-dose busulfan is dependent on the second alkylating agent used in the combined regimen (melphalan or thiotepa)J Bouligand, I Boland, D Valteau-Couanet, et al.
Pageof 26